As many of our sponsors continue moving to a hybrid model of decentralised trials, we’re expanding our integration capabilities and partner network to interact at the various touchpoints between IRT and DCT platforms to enable direct-to-patient and supply management. IXRS®3 platform features to support Decentralised Trials including…
Integration with CMO (Contract Manufacturing Organisation)
Integration with DCT providers
Supply Management
DTP (Direct To Patient) workflow management
DTP (Direct To Patient) workflow management
IXRS®3 Decentralised Trials Support Direct-to-Patient supply management
See how our technology will surpass your expectations, and experience how our seamless delivery will match your study-specifics regardless of size, phase, or complexity.
